Palisade Bio (PALI)Director bought ~$14K

~$14K

Approx. value · 10K sh @ $1.42

1.58M

Holds after · shares reported

Traded

Oct 1, 2026

Filed

Oct 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 10, 2026Company filing · Form 8-K · ResultsReported its results
2. Oct 1, 2026 · this disclosureInsider · Their largest buy since 2023Director purchased ~$14K of PALI shares in the open market

What came next

1. Oct 2, 2026InsiderDirector purchased ~$15K of PALI shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Palisade Bio

For Palisade Bio, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PALI page.

Other recent filings by Donald Allen Williams, Director

• SEC Form 4 at Palisade Bio (PALI)Oct 6, 2026
• SEC Form 4 at Palisade Bio (PALI)Jan 22, 2026
• SEC Form 4 at Palisade Bio (PALI)Jan 14, 2026

The full history of Donald Allen Williams, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Palisade Bio

• SEC Form 4Oct 6, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 4Jul 11, 2026
• SEC Form 4Jul 11, 2026
• SEC Form 4Jul 9, 2026
• SEC Form 4Jul 9, 2026

Everything OQRO holds on this company is on its PALI page.